BioCryst Reports Fourth Quarter and Full Year 2021 Financial Results and Upcoming Key Milestones
Go back to BioCryst Reports Fourth Quarter and Full Year 2021 Financial Results and Upcoming Key Milestones| BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) | Delayed: 9.17 +0.18 (2.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.99 | 52 Week High | $10.98 | |||
| Open | $9.04 | 52 Week Low | $1.63 | |||
| Day High | $9.24 | P/E | N/A | |||
| Day Low | $8.91 | EPS | $-0.68 | |||
| Volume | 695,357 | |||||
